ORAMED PHARMACEUTICALS INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ORMP

organization

SIC: 2834

Also known as: Oramed Pharmaceuticals Inc.

SEC Insider

$27.5M

394 transactions

Summary

ORAMED PHARMACEUTICALS INC. (ORMP) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $4.1MSales: $13.7M30 insiders

Date	Insider	Type	Value
2026-03-30	Kidron Miriam(Chief Scientific Officer)	F	$1.4M
2026-03-30	KIDRON NADAV(President and CEO)	F	$148K
2026-03-17	Gabay Avraham(Chief Financial Officer)	A	$0
2026-03-17	Hexter Joshua(COO & CBO)	A	$0
2026-03-17	KIDRON NADAV(President and CEO)	A	$0
2026-03-17	Kidron Miriam(Chief Scientific Officer)	A	$0
2026-03-12	KIDRON NADAV(President and CEO)	G	$0
2026-01-22	Gabay Avraham(Chief Financial Officer)	M	$0
2026-01-22	Gabay Avraham(Chief Financial Officer)	M	$0
2026-01-22	Hexter Joshua(COO & CBO)	M	$0
2026-01-22	Hexter Joshua(COO & CBO)	M	$0
2026-01-22	Kidron Miriam(Chief Scientific Officer)	M	$0
2026-01-22	Kidron Miriam(Chief Scientific Officer)	M	$0
2026-01-22	KIDRON NADAV(President and CEO)	M	$0
2026-01-22	KIDRON NADAV(President and CEO)	M	$0
2026-01-14	Kidron Miriam(Chief Scientific Officer)	G	$0
2025-12-31	Gabay Avraham(Chief Financial Officer)	A	$0
2025-12-31	Gabay Avraham(Chief Financial Officer)	A	$0
2025-12-31	Gabay Avraham(Chief Financial Officer)	A	$0
2025-12-31	Aghion Daniel	A	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ORAMED PHARMACEUTICALS INC. — Contributions, Lobbying & Contracts | Poliscope